EXPERIENCE OF MANAGEMENT OF THE PATIENT WITH THE RESYNCHRONIZATION BIVENTRICULAR PACING WITHOUT DESTRUCTION OF ATRIO-VENTRICULAR NODE SUFFERING FROM CHRONIC HEART FAILURE AND PERMA...

by I. V. Shanina, D. E. Volkov, D. A. Lopin
Published 2013-06-01

CHANGING OF THE DOSE COEFFICIENT OF THE MAJOR GROUPS OF DRUGS FOR PATIENTS WITH IMPLANTED PACEMAKERS, DEPENDING ON THE STAGE OF HYPERTENSION

by T. A. Derienko, D. E. Volkov, D. A. Lopin, M. I. Yabluchansky
Published 2017-06-01

THE QTC INTERVAL DURATION СLASS AND CLINICAL FEATURES OF PATIENTS WITH PACEMAKERS IN THE ACUTE POSTOPERATIVE PERIOD

by M. S. Maltseva, D. E. Volkov, D. A. Lopin, I. V. Soldatenko
Published 2013-06-01

QRS COMPLEX DURATION AND CLINICAL FEATURES OF PATIENTS WITH PERMANENT PACEMAKERS

by I. V. Shanina, D. E. Volkov, D. A. Lopin, N. I. Yabluchansky
Published 2013-06-01

FUNCTIONAL CLASS OF CHRONIC HEART FAILURE AND CLINICAL FEATURES OF PATIENTS WITH PERMANENT PACEMAKERS

by I. M. Kolomytseva, D. E. Volkov, D. A. Lopin, M. I. Yabluchansky
Published 2014-06-01